Pharmaceutical warehousing is not just about storing products; it’s a critical part of the supply chain that ensures the ...

However, Nifty's move towards 24,200 would not be in a linear manner as bouts of volatility in the backdrop of looming US ...

Currently, US charges nearly zero duties on pharmaceutical imports. India on the other hand imposes around 10 percent tax on ...

Stock market today: Indian pharma stocks extended their losing streak ... a lack of major product approvals, price control measures, and a ban on FDCs in India. Nifty Pharma delivered a close ...

For all doses, treatment with atumelnant resulted in a rapid, substantial, and sustained statistically significant reduction in A4 levels, the key biomarker for disease control. The analyst notes ...

Shares of NRx Pharmaceuticals, Inc. (NRXP) have been struggling lately and have lost 5.1% over the past week. However, a ...

JP Morgan's survey of endocrinologists finds strong awareness of Crinetics' atumelnant, with positive efficacy impressions.

Piramal believes that while passing the baton of the group's business, it is crucial for leaders—especially those accustomed ...

Two years after being fired, the founder of an eye drug development company formerly based in Farmington Hills is waging a proxy battle to take back control. Mina Sooch is a serial entrepreneur, ...

Unloxcyt is the first and only programmed death Stockholders of Checkpoint are set to obtain an upfront cash payment of $4.10 per share of common stock. Investing.com-- Sun Pharmaceutical (TADAWUL ...

UTC+8Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8MFirst-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical ...

Jyong Biotech Ltd. (Revived IPO) (MENS) is planning to raise $22 million in an initial public offering (IPO) on Thursday, April 3rd, IPO Scoop reports. The company plans to issue 2,700,000 shares at ...